Sionna Therapeutics, Inc.(SION)
$3.33-0.10 (-2.92%)
SION
Sionna Therapeutics, Inc. stock drug pipeline
$3.33
At close:-0.10 (-2.92%)
Want to see SION full AI Analyst Report?
Sionna Therapeutics, Inc. (SION) Drug Pipeline
71 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Sion-719 | Cystic Fibrosis (Cf) | Phase II | Recruiting | Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta | Jul 18, 2025 | ― |
| Sion-451, Sion-2222, Sion-109 | Cystic Fibrosis (Cf) | Phase I | Recruiting | Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants. | Jun 04, 2025 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Sion-719 | Phase II | Cystic Fibrosis (Cf) | Recruiting | Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta | Jul 18, 2025 | ― |
| Sion-451, Sion-2222, Sion-109 | Phase I | Cystic Fibrosis (Cf) | Recruiting | Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants. | Jun 04, 2025 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sionna Therapeutics, Inc. (SION) have in its pipeline
Sionna Therapeutics, Inc. SION is currently developing the following drugs: Sion-719, Sion-451, Sion-2222, Sion-109. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

